Advertisement
Home Tags Anticoagulants

Tag: Anticoagulants

Similar outcomes are seen for use of bivalirudin and heparin as anticoagulant agents in patients with ST-segment elevation myocardial infarction treated with radial primary percutaneous coronary intervention

Similar Outcomes for Bivalirudin, Heparin in STEMI With PCI

0
No significant difference in rate of composite end point of death, myocardial infarction, or stroke
Anticoagulants are often prescribed to prevent strokes in patients with atrial fibrillation

Anticoagulation May Help Prevent Dementia in A-Fib Patients

0
Dementia rates up with delays in anticoagulation treatment for atrial fibrillation
Anticoagulants are often prescribed to prevent strokes in patients with atrial fibrillation

Anticoagulation May Help Prevent Dementia in A-Fib Patients

0
Even patients with a low risk of stroke could benefit, researchers say
Electronic-health-based management of oral anticoagulation therapy is associated with fewer adverse events

E-Health-Based Management of Oral Anticoagulation Tx Beneficial

0
E-health-based coagulation service linked to lower frequency of adverse events
For acute coronary syndrome patients undergoing percutaneous coronary intervention and receiving clopidogrel

Ischemic Outcomes Don’t Vary With Gender in ACS Patients

0
No difference by gender for ACS patients undergoing PCI receiving clopidogrel, prasugrel, or ticagrelor
The risk of major bleeding is similar for older patients with atrial fibrillation taking either antiplatelet or anticoagulant drugs

Major Bleeding Risk From Drugs Similar in Elderly

0
Elderly taking aspirin, clopidogrel have major bleeding similar to that seen with oral anticoagulants
Patients with isolated superficial vein thrombosis have a similar overall risk of recurrence as those with proximal deep vein thrombosis

Overall Risk of VTE Recurrence Similar for iSVT, Proximal DVT

0
Isolated superficial vein thrombosis tied to increased risk of iSVT recurrence, lower risk of deep-VTE events
For patients undergoing dual antiplatelet therapy (DAPT) after percutaneous coronary intervention with a drug-eluting stent

DAPT Cessation Patterns Vary With Diabetes Status After PCI

0
Risk of major adverse cardiovascular events up for DAPT disruption, regardless of diabetes status
Among patients with intermediate- to high-risk pulmonary embolism

Long-Term Thrombolytic Tx No Benefit in Intermediate-Risk PE

0
Findings at three years for tenecteplase vs placebo in patients with intermediate-risk pulmonary embolism
Most patients have high confidence in self-testing their international normalized ratio

Patients Have High Confidence in Self-Testing INR

0
Seventy-three percent of patients report being confident in adjusting their own warfarin level